characteristic of immunoglobulin-binding proteins expressed by group A streptococci appears to be the absence of internal methionine residues in the binding protein. This has enabled development of a rapid, efficient, cyanogen bromide-based extraction procedure for solubilizing these molecules from intact bacteria. Studies carried out with a series of monospecific polyclonal antibodies prepared in chickens have identified two major antigenic classes of immunoglobulin-binding proteins. The methods described in this report facilitate a rapid functional and serological screening of immunoglobulin-binding proteins that should now enable detailed epidemiological studies of the importance of these molecules in group A streptococcal infections and their relationship to other surface proteins, in particular, the antiphagocytic M protein.
The ability to establish infections in humans requires a variety of factors produced by bacteria that enable them to colonize the host successfully, invade beyond mucosal or skin surfaces, and elude the host immune defenses. Each step of this process may be influenced by a different combination of bacterial factors, and accumulating evidence suggests that many of these molecules can be coordinately regulated as part of a virulence locus (20) . The presence of immunoglobulin-binding proteins on the surfaces of a variety of different human pathogens recently led to the suggestion that these molecules provide pathogens with the potential to evade or elude the host defense mechanisms (1, 5, 8, 35) . Studies in our laboratory have demonstrated the existence of five functionally distinct forms of immunoglobulin G (IgG)-binding proteins associated with group A streptococcal isolates (27) . Two group A streptococcal IgG-binding proteins have been cloned and sequenced and found to display significant sequence homology to antiphagocytic M proteins (13, 16) . In studies of a virulence locus in group A streptococci, the M protein, IgG-binding proteins, C5a peptidase, and, in some strains, IgA binding proteins may be constituents of a coordinately regulated virulence locus; evidence for a transacting regulatory protein has also been obtained (3, 10, 12, 24, 31) . To date, the importance of the expression of different functional forms of immunoglobulin-binding proteins for the virulence of group A streptococci has not been established. However, a recent study by Bessen and Fischetti, who measured the ability of intact organisms to bind to human IgG in a nonimmune fashion, did suggest an association between the expression of these functional molecules and the ability of group A organisms to colonize the * Corresponding author. The immunization protocol was that used previously to prepare antibodies to other bacterial binding proteins (29) . Essentially, each chicken was injected intramuscularly or subcutaneously with an immunogen containing approximately 50 ,g of affinity-purified type II protein emulsified in complete Freund's adjuvant. Three weeks later, each chicken was injected with approximately 50 ,ug of the same immunogen emulsified in incomplete Freund's adjuvant. Eggs were collected from the chickens and immunoglobulins were extracted from egg yolks as described previously (29) . The production of antibody was monitored by the ability of yolk extracts to inhibit binding of 1"I-labeled affinity-purifled type II protein to immobilized human IgG as described previously (29) .
Affinity purification of antibodies. For studies in which affinity-purified antibodies were prepared to be radiolabeled and used as probes in Western blot analysis, the chicken antibody was passed over a column of immobilized type II binding protein covalently coupled to Affi-Prep 10 (Bio-Rad) as described previously (23) . For preparation of the antibody specific to recombinant pLOH (otpLOH), the column was covalently coupled with a purified recombinant type Ila binding protein isolated as described previously (23) . For preparation of the affinity-purified antibody to the ITo protein (alIo), a CNBr extract of strain A928 was prepared as described above. After neutralization and extensive dialysis, this extract was coupled to Affi-Prep 10. Affinity purification was carried out by applying the respective chicken antibodies to the corresponding immobilized type II binding protein column in PBS (pH 7.3). Unbound proteins were removed by washing with this buffer, and bound antibody molecules were eluted selectively with 0.1 M glycine-HCl (pH 2). The recovered proteins were neutralized, dialyzed into PBS, and radioiodinated for use as specific probes.
Polyacrylamide gel electrophoresis and Western blotting techniques. Protein samples were denatured by boiling for 5 min in 0.5 M Tris-HCl (pH 6.8) containing 2% (wt/vol) SDS, 5% (vol/vol) 3-mercaptoethanol, 10% (vol/vol) glycerol, and 0.01% (wt/vol) bromphenol blue. Denatured proteins were electrophoresed on 10% polyacrylamide slab gels at 50 V for 16 h by the method of Laemmli (18) . Prestained molecular weight standards (Bio-Rad) containing phosphorylase b (110,000), bovine serum albumin (84,000), ovalbumin (47,000), carbonic anhydrase (33,000), soybean trypsin in-VOL. 30, 1992 (23) . Studies of protein G-positive human group C and G streptococci had demonstrated that CNBr treatment was an efficient method for solubilizing protein G (22) . This finding, coupled with analysis of the predicted distribution of methionine residues in the two type II IgG-binding protein genes thus far cloned and sequenced (13, 16) , suggested that the distribution of methionine residues within IgG-binding proteins might be a conserved feature of streptococcal IgG-binding proteins and that CNBr treatment may represent an efficient approach to solubilization of type II proteins. When group A strain 64/14 was treated with CNBr, all forms of IgG-binding protein known to be associated with this strain were recovered (23) .
Our studies documented the existence of five functionally distinct forms of type II IgG-binding proteins associated with group A streptococcal isolates (27) . These proteins were classified ( Western blotted and probed with each human IgG subclass, differences in subclass reactivity profiles could be identified (Fig. 2) Fig. 1 were run on four parallel SDS-10% polyacrylamide gels under reducing conditions. The separated proteins were transferred to a nitrocellulose membrane by electroblotting. Unreacted sites on the membranes were blocked, and the membranes were probed with the indicated radioiodinated human immunoglobulin subclasses. The probed membrane was washed and exposed to X-ray film with an intensifying screen for 18 h at -70°C. Lanes are as in Fig. 1 Fig. 4 and 5. representative group A strains were separated on SDS-10% polyacrylamide gels under reducing conditions. The separated proteins were transferred to nitrocellulose by electroblotting, unreacted sites on the membranes were blocked, and the membranes were probed with either an affinity-purified radioiodinated aIIo antibody or an apLOH antibody probe as indicated. The probed membranes were washed and exposed to X-ray film with intensifying screens for 24 h at -70°C. Lanes: 1, strain 64/14; 2, strain A207; 3, strain 11434; 4, strain A928A1; 5, strain A992. extracted proteins. The functional binding properties of each isolate could be accounted for on the basis of the previous classification of binding profiles with human IgG subclasses ( Table 1 ). The distribution of functional type II proteins in extracts from these strains is summarized in Table 4 .
Each extract was also analyzed serologically for reactivity with the oapLOH and alIIo affinity-purified antibody probes. Of 50 clinical isolates tested, 46 expressed immunoglobulinbinding proteins; of these, 45 isolates were reactive with either the apLOH or aIIo antibody probe. Only one strain expressed an IgG-binding protein that was not reactive, and two strains expressed antigenically related molecules without IgG-binding properties (Table 4) .
No absolute correlation between the reactivity with a given antibody and the functional activities of the protein was observed, except that strains expressing type IIa proteins were all associated with molecules that were reactive with the apLOH probe and those expressing type lIb pro- Fig. 4. teins, with the exception of the type Ilb protein from strain 64/14, were all associated with molecules reactive with the aIlo probe (Table 4) . Heterogeneity in immunoglobulinbinding activity for immunoglobulin-binding proteins belonging to either antigenic class was observed. Evidence for functional variation among type IIb IgG-binding proteins on the basis of their ability to be inhibited from binding to human IgG3 by streptococcal protein G was also noted (data not shown).
The distribution of immunoglobulin-binding proteins that were reactive with apLOH and otIIo observed for the Ohio Department of Health strains differed from the distributions of other strains obtained from the Lancefield Collection (Rockefeller University, New York, N.Y.), the University of Florida (College of Medicine, Gainesville), the University of Lund (Lund, Sweden), the Centers for Disease Control (Atlanta, Ga.), and the University of Minnesota (Minneapolis). Analysis of 50 group A strains from various geographical locations other than Ohio indicated a lower percentage of strains expressing IgG-binding proteins that reacted with apLOH. In this group, -25% reacted with apLOH and -75% reacted with aIIo, compared with an approximate 50:50 distribution observed for strains collected by the Ohio Department of Health (data not shown).
Association of type II IgG-binding protein classes and M (30, 32) . Recent genetic analysis of the chromosomal DNAs of certain group A strains has indicated that the IgG-binding protein could be encoded within a coordinately regulated virulence locus containing M protein, C5a peptidase, and perhaps other surface molecules (9, 10, 14, 15, 24, 31, 34) .
The importance of M proteins as antiphagocytic molecules that enable group A streptococci to avoid phagocytosis in human blood is well documented (11) . This antiphagocytic effect was further confirmed by studies in which an M protein gene was inserted into an M protein-negative bacterial host and expressed with concomitant acquisition of antiphagocytic properties (26, 33) . Resistance to phagocytosis could be overcome by addition of antibodies to unique M protein determinants. By contrast, the importance of IgGbinding proteins to the infectious process is not clear. An association between the expression of IgG-binding proteins and skin isolates has been suggested by Bessen and Fischetti (2) . These studies were carried out with laboratory isolates of group A strains in which the percentage of strains expressing IgG-binding proteins was lower than we observed with fresh clinical isolates in this study or that reported by Lindahl and Stenberg in another study of fresh clinical group A isolates (19) . It should also be noted that Bessen and Fischetti measured IgG binding to intact bacteria, whereas in this study functional proteins in bacterial extracts were analyzed. It is important in analyzing IgG-binding proteins to use fresh clinical isolates, since IgG-binding proteins can be lost by sequential laboratory passage (27) . We have also found that expression of surface proteins can be altered by passage of laboratory isolates through human blood or in mice; for example, compare the levels of expression of IgG-binding proteins in extracts of group A strain 64 after blood or mouse passage ( Fig. 1 and 2) .
It is clear that the importance of bacterial IgG-binding proteins in the pathogenic process or their usefulness as a marker for epidemiological studies will not emerge until a detailed classification system for these molecules is available. The studies presented in this report indicate that we now have efficient methods for solubilizing these proteins, in high yield, and serological reagents that can classify type II IgG-binding proteins into one of two major antigenic classes. Within each antigenic subgroup, we have evidence for a number of functional variants (Table 3 ). This pattern of subtle variation within antigenically related molecules is again reminiscent of the M protein; it is possible to delineate M proteins serologically into class I and class II and to classify strains further into serotypes on the basis of the expression of unique epitopes associated with the N-terminal portion on the protein (17) . The findings that M protein genes and IgG-binding protein genes display significant sequence homology (13, 16) and may be coordinately regulated as part of a group A streptococcal virulence locus (9, 10) raise additional questions as to the role these molecules play alone or together in the pathogenesis of group A streptococcal infections.
The study of type II IgG-binding proteins associated with group A streptococci is at an early stage by comparison with the extensive detailed structural and antigenic analysis of M proteins (for a review, see reference 11). However, the parallels between these two groups of molecules suggest that they are both members of a larger M protein supergene family, which may also include IgA-binding molecules (3, 12) . These molecules may have evolved from a common ancestral gene to provide the organism with complementary mechanisms to influence the interaction of bacteria with different host immune defense mechanisms. With the development of an efficient method of extraction of IgG-binding proteins, the availability of serological typing reagents, and the efficient methods of analyzing functional activity, it should now be possible to determine the role of specific type II IgG-binding proteins alone or in concert with the M protein and/or other products of a virulence locus in the ability of group A streptococci to cause infection or postinfection sequelae.
